Viking® (www.viking.com) (NYSE: VIK) has been named the 2024 North America IPO of the Year by International Financing Review (IFR) in the publication’s prestigious annual awards. The honor ...

2024 was an exceptionally busy year for Viking. During the year, the company reported successful results from four different studies across our pipeline. These include: the announcement of ...

"2024 was an exciting and extremely productive year for Viking," stated Brian Lian, Ph.D., chief executive officer of Viking. "During the year, the company reported positive data from four ...

LOS ANGELES, February 10, 2025--(BUSINESS WIRE)--Viking® (www.viking.com) (NYSE: VIK) has been named the 2024 North America IPO of the Year by International Financing Review (IFR) in the ...

Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared ...